(Q36950640)
Statements
1 reference
Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma (English)
1 reference
Thomas E Merchant
1 reference
Larry E Kun
1 reference
Matthew J Krasin
1 reference
Dana Wallace
1 reference
Murali M Chintagumpala
1 reference
Shiao Y Woo
1 reference
David M Ashley
1 reference
Maree Sexton
1 reference
Stewart J Kellie
1 reference
Verity Ahern
1 reference
Amar Gajjar
1 reference
24 September 2007
1 reference
1 reference
1 reference
Identifiers
1 reference